• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

EXENATIDE

Diabetes drugs for Alzheimer’s disease

September 5, 2018Metabolic Disorders, Nervous System Disorders, Vizit Graphs
Diabetes drugs for Alzheimer’s disease

Repurposing Diabetes drugs for Alzheimer’s disease. View pathways associated with the action of Exenatide in Alzheimer’s.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

COGNITION INFLAMMATORY RESPONSE TMPRSS2 HELICOBACTER PYLORI RAS NEUTROPHILS ESCHERICHIA COLI CELL DIFFERENTIATION CELL DEATH APOE ANGIOTENSIN II CANDIDA ALBICANS INSULIN STAPHYLOCOCCUS AUREUS ALZHEIMER'S DISEASE COAGULATION ACE LACTATE DEHYDROGENASE IFNG PARKINSON DISEASE IMMUNITY METFORMIN AGING RHEUMATOID ARTHRITIS ACE2 CHLOROQUINE CELL PROLIFERATION LISTERIA MONOCYTOGENES PD-1 IMMUNE RESPONSE CANCER CD4 PSEUDOMONAS AERUGINOSA IL6 SARS-COV-2 CASP3 IL1B INTERFERON TNF APOPTOTIC PROCESS COVID-19 NFKB1 AUTOPHAGY INFLAMMATION IL10

© 2020 Biovista Vizit All Rights Reserved.